TNF-α pretreated hematopoietic stem cells inhibit the migration and inflammatory response of HUVECs and attenuate GVHD

Hematologic diseases have seriously threatened human health. Although hematopoietic stem cell transplantation (HSCT) is an effective curative option, the complications, especially graft-versus-host disease (GVHD), are a big problem.